Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden-Reference-Cited by-同舟云学术

Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden

Published:2012-04 Issue:4 Volume:61 Page:690-700
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Van Hemelrijck Mieke,Garmo Hans,Holmberg Lars,Stattin Pär,Adolfsson Jan

Publisher

Elsevier BV

Subject

Urology

Reference33 articles.

1. Androgen deprivation therapy for prostate cancer;Sharifi;JAMA,2005

2. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy;Braga-Basaria;J Clin Oncol,2006

3. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer;Keating;J Clin Oncol,2006

4. Bicalutamide 150mg plus standard care vs standard care alone for early prostate cancer;Mcleod;BJU Int,2006

5. Petrylak PJ, WM. Androgen ablation for prostate cancer: mechanisms and modalities. In: Kantoff PW, Carroll P, D’Amico D, editors. Prostate cancer: principles and practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac risk factors and events in patients with prostate cancer commencing androgen deprivation therapy: analysis from a tertiary care centre in the Middle East;ecancermedicalscience;2022-09-14

2. Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group;Cancer/Radiothérapie;2020-12

3. Association of Androgen Deprivation Therapy and Thromboembolic Events: A Systematic Review and Meta-analysis;Urology;2018-04

4. Glucose metabolism during the acute prostate cancer treatment trajectory: The influence of age and obesity;Clinical Nutrition;2018-02

5. Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists—a nationwide population-based cohort study based on 2010–2013 French Health Insurance data;European Journal of Cancer;2017-05